• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性尼帕病毒感染的灭活方法。

Inactivation Methods for Experimental Nipah Virus Infection.

机构信息

WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.

German Center for Infection Research (DZIF), Partner Site Hamburg-Luebeck-Borstel-Reims, 38124 Braunschweig, Germany.

出版信息

Viruses. 2022 May 15;14(5):1052. doi: 10.3390/v14051052.

DOI:10.3390/v14051052
PMID:35632791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9145063/
Abstract

Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes severe disease in humans and livestock. Due to its high pathogenicity in humans and the lack of available vaccines and therapeutics, NiV needs to be handled in biosafety level 4 (BSL-4) laboratories. Safe inactivation of samples containing NiV is thus necessary to allow further processing in lower containment areas. To date, there is only limited information available on NiV inactivation methods validated by BSL-4 facilities that can be used as a reference. Here, we compare some of the most common inactivation methods in order to evaluate their efficacy at inactivating NiV in infected cells, supernatants and organs. Thus, several physical and chemical inactivation methods, and combinations thereof, were assessed. Viral replication was monitored for 3 weeks and NiV presence was assessed by RT-qPCR, plaque assay and indirect immunofluorescence. A total of nineteen methods were shown to reduce NiV infectious particles in cells, supernatants and organs to undetectable levels. Therefore, we provide a list of methods for the safe and efficient inactivation of NiV.

摘要

尼帕病毒(NiV)是一种新兴的人畜共患病副粘病毒,可导致人类和牲畜严重疾病。由于其在人类中的高致病性以及缺乏可用的疫苗和疗法,NiV 需要在生物安全 4 级(BSL-4)实验室中进行处理。因此,需要安全地灭活含有 NiV 的样本,以便在较低的控制区域进一步处理。迄今为止,只有有限的信息可用于 BSL-4 设施验证的 NiV 灭活方法,可作为参考。在这里,我们比较了一些最常见的灭活方法,以评估它们在灭活感染细胞、上清液和器官中的 NiV 的效果。因此,评估了几种物理和化学灭活方法及其组合。监测了 3 周的病毒复制,并通过 RT-qPCR、噬斑测定和间接免疫荧光评估 NiV 的存在。总共 19 种方法显示可将细胞、上清液和器官中的 NiV 感染性颗粒降低到无法检测的水平。因此,我们提供了一种安全有效地灭活 NiV 的方法列表。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/b19370d8b566/viruses-14-01052-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/851489f1cca7/viruses-14-01052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/e7d4326a11eb/viruses-14-01052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/404e6ad6b4e4/viruses-14-01052-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/c50b0d14fc54/viruses-14-01052-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/596c02842ee1/viruses-14-01052-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/b19370d8b566/viruses-14-01052-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/851489f1cca7/viruses-14-01052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/e7d4326a11eb/viruses-14-01052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/404e6ad6b4e4/viruses-14-01052-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/c50b0d14fc54/viruses-14-01052-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/596c02842ee1/viruses-14-01052-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9145063/b19370d8b566/viruses-14-01052-g006.jpg

相似文献

1
Inactivation Methods for Experimental Nipah Virus Infection.实验性尼帕病毒感染的灭活方法。
Viruses. 2022 May 15;14(5):1052. doi: 10.3390/v14051052.
2
Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories.有效灭活血清样本中的尼帕病毒,以确保在低生物安全实验室中安全处理。
Virol J. 2020 Oct 9;17(1):151. doi: 10.1186/s12985-020-01425-8.
3
Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.高效的反向遗传学揭示了尼帕病毒和亨德拉病毒之间出芽和融合差异的遗传决定因素,并能够在亨尼帕病毒感染的小动物模型中实时监测病毒传播。
J Virol. 2015 Jan 15;89(2):1242-53. doi: 10.1128/JVI.02583-14. Epub 2014 Nov 12.
4
Evaluation of henipavirus chemical inactivation methods for the safe removal of samples from the high-containment PC4 laboratory.评估亨德拉病毒化学灭活方法,以安全地从高防护级别 PC4 实验室中移除样本。
J Virol Methods. 2021 Dec;298:114287. doi: 10.1016/j.jviromet.2021.114287. Epub 2021 Sep 13.
5
Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.尼帕病毒和亨德拉病毒糖蛋白诱导可比的同源但不同的异源融合表型。
J Virol. 2019 Jun 14;93(13). doi: 10.1128/JVI.00577-19. Print 2019 Jul 1.
6
Development of a neutralization assay for Nipah virus using pseudotype particles.利用假型颗粒开发尼帕病毒中和试验。
J Virol Methods. 2009 Sep;160(1-2):1-6. doi: 10.1016/j.jviromet.2009.02.025. Epub 2009 Mar 9.
7
Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle.新型转录和复制型病毒样颗粒系统模拟尼帕病毒生命周期。
Emerg Microbes Infect. 2024 Dec;13(1):2368217. doi: 10.1080/22221751.2024.2368217. Epub 2024 Jul 5.
8
Molecular characteristics of the Nipah virus glycoproteins.尼帕病毒糖蛋白的分子特征
Ann N Y Acad Sci. 2007 Apr;1102:39-50. doi: 10.1196/annals.1408.003.
9
Rousettus aegyptiacus Bats Do Not Support Productive Nipah Virus Replication.埃及果蝠不支持尼帕病毒的有效复制。
J Infect Dis. 2020 May 11;221(Suppl 4):S407-S413. doi: 10.1093/infdis/jiz429.
10
Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro.尼帕病毒在体内和体外的器官和内皮趋向性。
Thromb Haemost. 2009 Dec;102(6):1014-23. doi: 10.1160/TH09-05-0310.

引用本文的文献

1
Harnessing Hazara Virus as a Surrogate for Crimean-Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level.利用哈扎拉病毒作为克里米亚-刚果出血热病毒的替代物可在低生物安全水平下进行灭活研究。
Pathogens. 2025 Jul 15;14(7):700. doi: 10.3390/pathogens14070700.
2
molecular analysis and blocking of the viral G protein of Nipah virus interacting with ephrin B2 and B3 receptor by using peptide mass fingerprinting.利用肽质量指纹图谱对与埃菲林B2和B3受体相互作用的尼帕病毒的病毒G蛋白进行分子分析和阻断
Front Bioinform. 2025 Jun 25;5:1526566. doi: 10.3389/fbinf.2025.1526566. eCollection 2025.
3
Virucidal Approaches for Hemorrhagic Fever Viruses.

本文引用的文献

1
Drivers and Distribution of Henipavirus-Induced Syncytia: What Do We Know?亨德拉尼帕病毒诱导合胞体的形成机制及其传播途径:我们了解多少?
Viruses. 2021 Sep 2;13(9):1755. doi: 10.3390/v13091755.
2
Evaluation of henipavirus chemical inactivation methods for the safe removal of samples from the high-containment PC4 laboratory.评估亨德拉病毒化学灭活方法,以安全地从高防护级别 PC4 实验室中移除样本。
J Virol Methods. 2021 Dec;298:114287. doi: 10.1016/j.jviromet.2021.114287. Epub 2021 Sep 13.
3
Validation of Inactivation Methods for Arenaviruses.验证沙粒病毒的灭活方法。
出血热病毒的杀病毒方法。
Viruses. 2025 Apr 30;17(5):663. doi: 10.3390/v17050663.
4
Successful Inactivation of High-Consequence Pathogens in PrimeStore Molecular Transport Media.在PrimeStore分子转运介质中成功灭活高致病性病原体
Viruses. 2025 Apr 29;17(5):639. doi: 10.3390/v17050639.
5
Implementation of RT-RAA and CRISPR/Cas13a for an NiV Point-of-Care Test: A Promising Tool for Disease Control.实时重组酶介导等温扩增(RT-RAA)和CRISPR/Cas13a在尼帕病毒即时检测中的应用:一种用于疾病控制的有前景的工具。
Viruses. 2025 Mar 27;17(4):483. doi: 10.3390/v17040483.
6
Heat Inactivation of Nipah Virus for Downstream Single-Cell RNA Sequencing Does Not Interfere with Sample Quality.用于下游单细胞RNA测序的尼帕病毒热灭活不影响样本质量。
Pathogens. 2024 Jan 9;13(1):62. doi: 10.3390/pathogens13010062.
7
Art of the Kill: Designing and Testing Viral Inactivation Procedures for Highly Pathogenic Negative Sense RNA Viruses.杀戮的艺术:设计和测试高致病性负链RNA病毒的病毒灭活程序
Pathogens. 2023 Jul 19;12(7):952. doi: 10.3390/pathogens12070952.
8
Establishment of an Inactivation Method for Ebola Virus and SARS-CoV-2 Suitable for Downstream Sequencing of Low Cell Numbers.建立一种适用于低细胞数下游测序的埃博拉病毒和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)灭活方法。
Pathogens. 2023 Feb 17;12(2):342. doi: 10.3390/pathogens12020342.
9
Aerosol Survival, Disinfection and Formalin Inactivation of Nipah Virus.尼帕病毒气溶胶存活、消毒和福尔马林失活。
Viruses. 2022 Sep 16;14(9):2057. doi: 10.3390/v14092057.
Viruses. 2021 May 24;13(6):968. doi: 10.3390/v13060968.
4
Quantification of Ebola virus replication kinetics in vitro.体外埃博拉病毒复制动力学的定量分析。
PLoS Comput Biol. 2020 Nov 2;16(11):e1008375. doi: 10.1371/journal.pcbi.1008375. eCollection 2020 Nov.
5
Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories.有效灭活血清样本中的尼帕病毒,以确保在低生物安全实验室中安全处理。
Virol J. 2020 Oct 9;17(1):151. doi: 10.1186/s12985-020-01425-8.
6
Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity.鉴定能抑制肺炎球菌溶血素功能活性的单克隆抗体识别位点。
Biomolecules. 2020 Jul 8;10(7):1009. doi: 10.3390/biom10071009.
7
Survival and persistence of Nipah virus in blood and tissue culture media.在血液和组织培养液中尼帕病毒的存活和持续存在。
Emerg Microbes Infect. 2019;8(1):1760-1762. doi: 10.1080/22221751.2019.1698272.
8
Infectious disease and economics: The case for considering multi-sectoral impacts.传染病与经济学:考虑多部门影响的理由
One Health. 2019 Jan 9;7:100080. doi: 10.1016/j.onehlt.2018.100080. eCollection 2019 Jun.
9
Direct cell-to-cell transmission of respiratory viruses: The fast lanes.呼吸道病毒的细胞间直接传播:快速通道。
PLoS Pathog. 2018 Jun 28;14(6):e1007015. doi: 10.1371/journal.ppat.1007015. eCollection 2018 Jun.
10
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines.包膜病毒的共同特征及其对下一代疫苗免疫原设计的意义。
Cell. 2018 Mar 8;172(6):1319-1334. doi: 10.1016/j.cell.2018.02.054.